Does CANAGLIFLOZIN Cause Toe amputation? 2,193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,193 reports of Toe amputation have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 9.0% of all adverse event reports for CANAGLIFLOZIN.
2,193
Reports of Toe amputation with CANAGLIFLOZIN
9.0%
of all CANAGLIFLOZIN reports
19
Deaths
1,647
Hospitalizations
How Dangerous Is Toe amputation From CANAGLIFLOZIN?
Of the 2,193 reports, 19 (0.9%) resulted in death, 1,647 (75.1%) required hospitalization, and 6 (0.3%) were considered life-threatening.
Is Toe amputation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 2,193 reports have been filed with the FAERS database.
What Other Side Effects Does CANAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,413)
Osteomyelitis (2,146)
Acute kidney injury (1,853)
Fungal infection (1,385)
Gangrene (1,081)
Weight decreased (1,014)
Cellulitis (1,007)
Urinary tract infection (920)
Diabetic foot infection (832)
Leg amputation (792)
What Other Drugs Cause Toe amputation?
CANAGLIFLOZIN\METFORMIN (196)
EMPAGLIFLOZIN (149)
INSULIN GLARGINE (133)
ADALIMUMAB (124)
METFORMIN (103)
BECAPLERMIN (102)
ETANERCEPT (100)
METHOTREXATE (84)
TOCILIZUMAB (66)
DAPAGLIFLOZIN (64)
Which CANAGLIFLOZIN Alternatives Have Lower Toe amputation Risk?
CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN
CANAGLIFLOZIN vs CANAKINUMAB
CANAGLIFLOZIN vs CANDESARTAN
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE